S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 83 TWD -0.12% Market Closed
Market Cap: 9.9B TWD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
SCI Pharmtech Inc

There are no price targets for SCI Pharmtech Inc.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
SCI Pharmtech Inc Competitors:
Price Targets
4746
Formosa Laboratories Inc
58% Upside
C
1093
CSPC Pharmaceutical Group Ltd
48% Upside
4530
Hisamitsu Pharmaceutical Co Inc
16% Upside
600085
Beijing Tongrentang Co Ltd
33% Upside
4746
Formosa Laboratories Inc
58% Upside
C
1093
CSPC Pharmaceutical Group Ltd
48% Upside
4530
Hisamitsu Pharmaceutical Co Inc
16% Upside
600085
Beijing Tongrentang Co Ltd
33% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
9% Downside
NEU
Neuren Pharmaceuticals Ltd
109% Upside
6996
Antengene Corporation Ltd
61% Downside
P
603566
Pulike Biological Engineering Inc
28% Upside

Revenue
Forecast

Revenue Estimate
SCI Pharmtech Inc

For the last 8 years the compound annual growth rate for SCI Pharmtech Inc's revenue is -5%. The projected CAGR for the next 2 years is 26%.

-5%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SCI Pharmtech Inc

For the last 8 years the compound annual growth rate for SCI Pharmtech Inc's operating income is -12%.

-12%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SCI Pharmtech Inc

For the last 8 years the compound annual growth rate for SCI Pharmtech Inc's net income is -3%. The projected CAGR for the next 2 years is -20%.

-3%
Past Growth
-20%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SCI Pharmtech Inc's stock price target?
Not Available

SCI Pharmtech Inc doesn't have any price targets made by Wall Street professionals.

What is SCI Pharmtech Inc's Revenue forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for SCI Pharmtech Inc's revenue is -5%. The projected CAGR for the next 2 years is 26%.

What is SCI Pharmtech Inc's Net Income forecast?
Projected CAGR
-20%

For the last 8 years the compound annual growth rate for SCI Pharmtech Inc's net income is -3%. The projected CAGR for the next 2 years is -20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 240,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.